Proceedings Paper
Photodynamic therapy of cancer by photogem| Format | Member Price | Non-Member Price |
|---|---|---|
| $17.00 | $21.00 |
Paper Abstract
The first experience of photodynamic therapy (PDT) in Russia is presented. Thirty-three patients have been treated by PDT since February 1992 with a photosensitizer from the hematoporphirine group -- Photogem. The follow-up results (5th - 18th months) have been controlled in all patients with skin cancer and basalioma, cancer of the tongue, lower lip and oral mucous, breast cancer, lung cancer and tumor of other locations. Positive effect has been observed in 30 patients (90.9%). Total regression of the tumor was seen in 16 patients (48.5%) and partial reduction -- in 14 cases (42.4%).
Paper Details
Date Published: 1 March 1994
PDF: 3 pages
Proc. SPIE 2078, Photodynamic Therapy of Cancer, (1 March 1994); doi: 10.1117/12.168695
Published in SPIE Proceedings Vol. 2078:
Photodynamic Therapy of Cancer
Giulio Jori; Johan Moan; Willem M. Star, Editor(s)
PDF: 3 pages
Proc. SPIE 2078, Photodynamic Therapy of Cancer, (1 March 1994); doi: 10.1117/12.168695
Show Author Affiliations
Eugeny Ph. Stranadko, State Research Ctr. for Laser Medicine (Russia)
Oleg K. Skobelkin, State Research Ctr. for Laser Medicine (Russia)
Oleg K. Skobelkin, State Research Ctr. for Laser Medicine (Russia)
Andry E. Mironov, State Research Ctr. for Laser Medicine (Russia)
Published in SPIE Proceedings Vol. 2078:
Photodynamic Therapy of Cancer
Giulio Jori; Johan Moan; Willem M. Star, Editor(s)
© SPIE. Terms of Use
